Moderna, Nike and TSMC among pandemic-era outperformers in patent portfolio strength
Innovation metric that’s agnostic to patent quantity highlights diverse group of companies that have put distance between themselves and their competition over the past two years
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.